CA2345230A1 - Procede selectif d'inactivation de virus dans des compositions biologiques - Google Patents
Procede selectif d'inactivation de virus dans des compositions biologiques Download PDFInfo
- Publication number
- CA2345230A1 CA2345230A1 CA002345230A CA2345230A CA2345230A1 CA 2345230 A1 CA2345230 A1 CA 2345230A1 CA 002345230 A CA002345230 A CA 002345230A CA 2345230 A CA2345230 A CA 2345230A CA 2345230 A1 CA2345230 A1 CA 2345230A1
- Authority
- CA
- Canada
- Prior art keywords
- preparation
- composition
- ethyleneimine oligomer
- solution
- washing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2796/00—Viruses not covered by groups C12N2710/00 - C12N2795/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
L'invention porte sur un procédé d'inactivation de virus d'animaux dans une préparation de cellules purifiées de mammifères qui arrivées à maturité n'ont pas de noyau (par exemple des globules rouges ou des plaquettes), consistant à mettre en contact la préparation avec un agent inactivateur sélectif, oligomère d'éthylèneimine, dans des conditions d'inactivation pendant un temps suffisant pour inactiver au moins certains virus de la préparation. L'invention porte également sur un procédé d'extraction, après le processus d'inactivation, des virus dudit agent inactivateur de la composition biologique traitée, sans adjonction d'un agent d'extinction.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16103098A | 1998-09-25 | 1998-09-25 | |
US09/161,030 | 1998-09-25 | ||
PCT/US1999/021245 WO2000018969A1 (fr) | 1998-09-25 | 1999-09-22 | Procede selectif d'inactivation de virus dans des compositions biologiques |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2345230A1 true CA2345230A1 (fr) | 2000-04-06 |
Family
ID=22579508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002345230A Abandoned CA2345230A1 (fr) | 1998-09-25 | 1999-09-22 | Procede selectif d'inactivation de virus dans des compositions biologiques |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1115889A4 (fr) |
JP (1) | JP2002525131A (fr) |
AU (1) | AU6497099A (fr) |
CA (1) | CA2345230A1 (fr) |
WO (1) | WO2000018969A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6617100B2 (en) | 1998-09-25 | 2003-09-09 | V.I. Technologies, Inc. | Solid phase quenching systems |
US6403359B1 (en) | 1998-09-25 | 2002-06-11 | V. I. TECHNOLOGIES, Inc. | Solid phase quenching systems |
US6150109A (en) | 1999-01-25 | 2000-11-21 | V. I. TECHNOLOGIES, Inc. | Lipophilic quenching of viral inactivating agents |
US20020131958A1 (en) * | 2001-01-22 | 2002-09-19 | John Chapman | Method for purifying a biological composition |
US20050074743A1 (en) * | 2003-10-06 | 2005-04-07 | Purmal Andrei A. | Method and composition for treating a biological sample |
DE102005021363A1 (de) * | 2005-05-04 | 2006-11-16 | Basf Ag | Biozide Beschichtungen |
CN101012455B (zh) * | 2005-11-14 | 2011-05-18 | 大连珍奥药业有限公司 | 一种生化物质的灭活方法、一种心肌肽素的制备方法及其用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6114108A (en) * | 1995-08-29 | 2000-09-05 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of viral nucleic acids |
-
1999
- 1999-09-22 CA CA002345230A patent/CA2345230A1/fr not_active Abandoned
- 1999-09-22 AU AU64970/99A patent/AU6497099A/en not_active Abandoned
- 1999-09-22 JP JP2000572416A patent/JP2002525131A/ja active Pending
- 1999-09-22 WO PCT/US1999/021245 patent/WO2000018969A1/fr not_active Application Discontinuation
- 1999-09-22 EP EP99952914A patent/EP1115889A4/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1115889A4 (fr) | 2003-02-05 |
WO2000018969A1 (fr) | 2000-04-06 |
AU6497099A (en) | 2000-04-17 |
EP1115889A1 (fr) | 2001-07-18 |
JP2002525131A (ja) | 2002-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Webert et al. | Proceedings of a consensus conference: pathogen inactivation—making decisions about new technologies | |
Seltsam et al. | UVC irradiation for pathogen reduction of platelet concentrates and plasma | |
Bihl et al. | Transfusion-transmitted infections | |
EP1838355B1 (fr) | Procedes d'inhibition ameliores destines a un processus d'inactivation de globules rouges | |
Bryant et al. | Pathogen inactivation: the definitive safeguard for the blood supply | |
Klein | Pathogen inactivation technology: cleansing the blood supply | |
Kleinman et al. | Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation | |
JP4968974B2 (ja) | 血液製剤からソラレンを除去するための方法およびデバイス | |
JP4643004B2 (ja) | 生体材料中の病原体不活性化剤をクエンチするための方法 | |
Goodrich et al. | Defining “adequate” pathogen reduction performance for transfused blood components | |
Li et al. | Prevalence of antibody to malignant catarrhal fever virus in wild and domestic ruminants by competitive-inhibition ELISA | |
US20230263833A1 (en) | Compositions and methods for preparation of red blood cells | |
McCullough | Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections | |
EP1912681A2 (fr) | Procedes pour limiter la quantite d'agents pathogenes presents dans des echantillons biologiques | |
Terpstra et al. | Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates | |
Corash | Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: current research perspectives | |
KR20140093603A (ko) | 병원체 불활성화제로서의 글리콜 | |
CA2345230A1 (fr) | Procede selectif d'inactivation de virus dans des compositions biologiques | |
Dodd | Current safety of the blood supply in the United States | |
Trimble et al. | Assessing emerging infectious threats to blood safety for the blood disorders community | |
US20020034724A1 (en) | Methods to selectively inactivate microorganisms in biological compositions | |
Rios et al. | Viability of red cells prepared with S‐303 pathogen inactivation treatment | |
Rosskopf et al. | Pathogen reduction of double‐dose platelet concentrates from pools of eight buffy coats: product quality, safety, and economic aspects | |
Seghatchian et al. | Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates | |
Nakazawa et al. | A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |